The Global Portable Diagnostics Devices market size  was valued at US$ 64.85 million in 2024 and is projected to reach US$ 104.66 million by 2033, growing at a CAGR of 5.5% during the forecast period from 2025 to 2033.The portable diagnostics devices market is growing due to rising demand for rapid, point-of-care testing and increasing prevalence of chronic and infectious diseases. Technological advancements in miniaturized, AI-enabled devices and growing adoption of remote patient monitoring are boosting efficiency and usability. Additionally, increased healthcare awareness and higher spending in developing regions are driving market growth.

Recent Launch in U.S Market:- In July 2025, Hitachi Healthcare launched portable imaging solutions, including handheld ultrasound and X-ray devices, aimed at enhancing accessibility and rapid diagnostics in regional hospitals and remote care settings. Early trials have reported higher adoption rates and improved workflow efficiency, marking a significant advancement in portable diagnostic technology in the U.S.  

Recent Launches in Japan Market :- In August 2025, Esaote introduced the MyLab C30 Cardio, a portable ultrasound device designed for advanced cardiac evaluations. This device incorporates AI tools like the HeartScan Assistant for guidance and quality optimization, reflecting Japan's commitment to integrating cutting-edge technology in portable diagnostics.

📌 Download your Sample Report Instantly - Corporate Email ID required for priority access:-https://www.datamintelligence.com/download-sample/portable-diagnostics-devices-market?oppj 

Market segmentation-

  -By Product Type: The market encompasses devices such as handheld devices, portable imaging devices, wearable diagnostics, and multi-functional analyzers. The fastest growing segments remain handheld devices and portable imaging devices, owing to their user-friendliness and quick diagnoses.

  -By Technology: Several technologies, including ultrasound, ECG, blood analyzers, biosensors, and imaging systems, are being vital in driving the adoption of portable diagnostics. AI and other IoT solutions improve portability, accuracy, and real-time monitoring.

  -By Application: Major applications of portable diagnostics include point- of-care testing, home healthcare, emergency care, and telemedicine. The demand for quick results and remote patient monitoring continues to drive adoption in these applications.

Market drivers:- 

  -Growing Demand for Point-of-Care Testing: Increased need for rapid and accurate testing in hospitals, outpatient facilities, and home health settings is fueling the market.

  -Rise of Chronic and Infectious Diseases: Increased instances of chronic diseases such as diabetes and cardiovascular diseases, characteristics of the infectious disease landscape, are driving the demand for portable diagnostic testing solutions.

  -Use of New Technology: Advances and innovations in miniaturized devices, integration with AI, wireless connectivity and Internet of Things (IoT)-enabled diagnostics have improved usability, improved accuracy and created real-time monitoring capabilities.

  -Remote Patient Monitoring and Home Health: The rise of telemedicine and functionality that allows for continuous health monitoring have led to increased readily-available health checks through portable diagnostic tools.

  -Increase in Healthcare Spending: An increase in spending dedicated to healthcare infrastructure, particularly in developing countries, has contributed to improvements in health spending and market growth.

Market Key players:- 

  -Abbott Laboratories

  -F. Hoffmann-La Roche Ltd

  -Siemens Healthineers

  -GE Healthcare

  -Philips Healthcare

  -Medtronic

  -LifeScan, Inc.

  -Nova Biomedical
  -Becton, Dickinson and Company (BD)

  -Axxin

Recent Development in 2025-

  -In August 2025, Mumbai introduced AI-enabled portable X-ray machines to rapidly identify presumptive tuberculosis (TB) cases. These machines, deployed in health camps and fixed facilities like BMC hospitals and TB centers, analyze chest scans and provide preliminary results in minutes. During a recent 100-day TB detection campaign, 100 CAD machines were distributed across Maharashtra, with Mumbai receiving 24 from the state and acquiring 24 more through corporate funding. Over 10,000 scans have been conducted in the city so far.

  -In September 2025, the Punjab government launched AI-enabled screening devices aimed at the early detection of breast cancer, cervical cancer, and vision impairments. Partnering with ACT Grants, the program introduced portable, radiation-free devices across eight districts:

Thermalytix by Niramai for breast cancer, Smart Scope by Periwinkle for cervical cancer, and a Portable Autorefractometer by Forus Health for eye screenings. The initiative aims to conduct at least 600 eye and 300 cancer screenings daily, particularly in rural areas.

  -In July 2025, Becton, Dickinson and Company (BD) announced a $17.5 billion merger with Waters Corporation's Biosciences & Diagnostic Solutions division. The merger aims to strengthen BD's position in the diagnostics market, focusing on bioseparations, bioanalytical characterization, and multiplex diagnostics. The combined entity is projected to generate $6.5 billion in revenue in 2025 and is expected to increase adjusted earnings per share in its first year. The deal is anticipated to be completed in the first quarter of 2026.

Benefits of the report-

  -The portable diagnostics devices market report provides valuable insights for stakeholders to make informed decisions. It offers a clear understanding of market size, growth trends, and future projections, helping businesses identify opportunities in healthcare and diagnostics. The report highlights key players, their strategies, and recent developments, enabling competitive benchmarking and partnership planning. It also provides insights into emerging technologies and innovations enhancing point-of-care testing and remote monitoring. Additionally, the report aids in strategic planning, risk mitigation, and forecasting, supporting healthcare providers, manufacturers, and investors in resource allocation and market expansion decisions.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

 ☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring 

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

 Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

Contact Information 

Company: DataM Intelligence 

Contact Person: Sai Kiran 

Email: Sai.k@datamintelligence.com 

Phone: +1 877 441 4866 

Website: https://www.datamintelligence.com